CN103638485A - Chinese medicinal composition for treating dyspepsia of hepatopathy patients - Google Patents

Chinese medicinal composition for treating dyspepsia of hepatopathy patients Download PDF

Info

Publication number
CN103638485A
CN103638485A CN201310597932.4A CN201310597932A CN103638485A CN 103638485 A CN103638485 A CN 103638485A CN 201310597932 A CN201310597932 A CN 201310597932A CN 103638485 A CN103638485 A CN 103638485A
Authority
CN
China
Prior art keywords
parts
drugs
chinese medicinal
medicinal composition
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310597932.4A
Other languages
Chinese (zh)
Other versions
CN103638485B (en
Inventor
关纯
李谦
刘彩云
阎青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Municipal Hospital
Original Assignee
Qingdao Municipal Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Municipal Hospital filed Critical Qingdao Municipal Hospital
Priority to CN201310597932.4A priority Critical patent/CN103638485B/en
Publication of CN103638485A publication Critical patent/CN103638485A/en
Application granted granted Critical
Publication of CN103638485B publication Critical patent/CN103638485B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a Chinese medicinal composition for treating dyspepsia of hepatopathy patients. The Chinese medicinal composition comprises the following components by weight: 30-40 parts of atratylodes rhizome, 30-40 parts of Magnolia officinalis, 30-40 parts of papaya, 30-40 parts of medicated leaven, 20-30 parts of Cyperus rotundus, 20-30 parts of radix bupleuri, 20-30 parts of China rose, 20-30 parts of Radix Linderae, 10-20 parts of fresh ginger, and 10-20 parts of gentian. The Chinese medicinal composition for treating dyspepsia of hepatopathy patients provided by the invention has reasonable prescription. Specifically, the atratylodes rhizome can drying dampness and strengthening spleen, the Magnolia officinalis can promote the circulation of qi, eliminate dampness and remove qi stagnation, the papaya can remove dampness to restore stomach, the medicated leaven can help digestion and harmonize the stomach, and the four drugs together serve as monarch drugs. The Cyperus rotundus can soothe liver and regulate qi flowing, regulate menstruation and relieve pain, the radix bupleuri can soothe liver and resolve depression, the China rose can promote blood circulation to regulate menstruation, dispel depression and diminish swelling, the Radix Linderae can promote qi circulation and relieve pain, and the four drugs together serve as minister drugs. The fresh ginger can relieve exterior syndromes by diaphoresis, warm the middle jiao and arrest vomiting, the gentian can clear away heat and dry dampness, and purge liver fire, and the two drugs together serve as assistant drugs. The ten drugs can be used cooperatively to achieve the efficacy of drying dampness, tonifying spleen, soothing liver and resolving depression. The Chinese medicinal composition provided by the invention has the characteristics of convenient use, significant effect, and can effectively treat dyspepsia of hepatopathy patients.

Description

A kind of dyspeptic Chinese medicine composition of hepatopath for the treatment of
Technical field
The present invention relates to Chinese medicine composition, particularly a kind of dyspeptic Chinese medicine composition of hepatopath for the treatment of.
Background technology
Dysfunction by aspects such as the complete caused gastral motion of liver function, absorption, secretion, barrier, blood circulations, is referred to as liver property gastrointestinal function incomplete, and a lot of hepatopaths usually be take dyspepsia and gone to a doctor as onset symptoms; And the functional dyspepsia that meets the diagnostic criteria of Rome III is common especially clinically.Most dyspepsia patients have period of digestion and interdigestive phase dyskinesia, and gastric emptying is the leading indicator of evaluating period of digestion function.
Hepatopath's dyspepsia main manifestations is side of body rib distension pain, uncomfortable in chest heaving a deep sigh, spirit depressing, irascible temperament, the decreased food intake of receiving is few, and tastelessness is dull, the vexed abdominal distention of gastral cavity, in the afternoon for very, deficiency of QI with disinclination to talk, extremity asthenia, shallow complexion, diarrhea or food indigested food, every because of take food raw food greasy and stodgy food increase the weight of.Pale tongue has indentation, and tongue is white, deep and stringy pulse.
Summary of the invention
For the defect existing in prior art, the object of the present invention is to provide the dyspeptic Chinese medicine composition of a kind of hepatopath for the treatment of.
Technical scheme of the present invention is as follows:
Treat the dyspeptic Chinese medicine composition of hepatopath, by following component, according to weight fraction, formed:
Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.
The dyspeptic Chinese medicine composition for the treatment of hepatopath as above, is comprised of according to weight fraction following component:
35 parts of Rhizoma Atractylodis, 35 parts of Cortex Magnoliae Officinalis, 35 parts of Fructus Chaenomeliss, 35 parts of Massa Medicata Fermentata, 25 parts of Rhizoma Cyperis, 25 parts of Radix Bupleuri, 25 parts of Flos Rosae Chinensiss, 25 parts of the Radixs Linderae, 15 parts, Rhizoma Zingiberis Recens, 15 parts of Radix Gentianaes.
The dyspeptic Chinese medicine composition for the treatment of hepatopath of the present invention, reasonable recipe, in side, Rhizoma Atractylodis are drying damp and strengthening spleen, Cortex Magnoliae Officinalis circulation of qi promoting, dampness, removing food stagnancy, Fructus Chaenomelis removing dampness to restore normal function of the stomach, the Massa Medicata Fermentata stomach function regulating that helps digestion, four medicines are monarch drug altogether; Rhizoma Cyperi depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving, Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, Flos Rosae Chinensis promoting blood flow to regulate menstruation, resolving depression detumescence, Radix Linderae promoting the circulation of QI to relieve pain, four medicines are ministerial drug altogether, Rhizoma Zingiberis Recens relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, Radix Gentianae heat clearing and damp drying, removing fire from the liver, be adjuvant drug altogether, ten medicines share, the effect of playing altogether dampness, spleen invigorating, stomach function regulating, dispersing the stagnated live-QI to relieve the stagnation of QI.Drug use of the present invention is convenient, effect is remarkable, effectively treats the disease of hepatopath's dyspepsia.
The specific embodiment
Embodiment 1
Treat the dyspeptic Chinese medicine composition of hepatopath, by following component, according to weight fraction, form (every part of 1g):
30 parts of Rhizoma Atractylodis, 30 parts of Cortex Magnoliae Officinalis, 30 parts of Fructus Chaenomeliss, 30 parts of Massa Medicata Fermentata, 20 parts of Rhizoma Cyperis, 20 parts of Radix Bupleuri, 20 parts of Flos Rosae Chinensiss, 20 parts of the Radixs Linderae, 10 parts, Rhizoma Zingiberis Recens, 10 parts of Radix Gentianaes.
Preparation method is as follows:
Take according to quantity various components in above-mentioned composition, join in 800 parts of water, boil 30 minutes, filter, abandon filtering residue, filtrate is concentrated into 200 parts.
Embodiment 2
The dyspeptic Chinese medicine composition for the treatment of hepatopath as above, forms (every part of 1g) by following component according to weight fraction:
35 parts of Rhizoma Atractylodis, 35 parts of Cortex Magnoliae Officinalis, 35 parts of Fructus Chaenomeliss, 35 parts of Massa Medicata Fermentata, 25 parts of Rhizoma Cyperis, 25 parts of Radix Bupleuri, 25 parts of Flos Rosae Chinensiss, 25 parts of the Radixs Linderae, 15 parts, Rhizoma Zingiberis Recens, 15 parts of Radix Gentianaes.
Preparation method is with embodiment 1.
Embodiment 3
Treat the dyspeptic Chinese medicine composition of hepatopath, by following component, according to weight fraction, form (every part of 1g):
40 parts of Rhizoma Atractylodis, 40 parts of Cortex Magnoliae Officinalis, 40 parts of Fructus Chaenomeliss, 40 parts of Massa Medicata Fermentata, 30 parts of Rhizoma Cyperis, 30 parts of Radix Bupleuri, 30 parts of Flos Rosae Chinensiss, 30 parts of the Radixs Linderae, 20 parts, Rhizoma Zingiberis Recens, 20 parts of Radix Gentianaes.
Preparation method is with embodiment 1.
Experimental example
Choose patient's 80 examples in hepatopath with indigestion symptom, take the medicine of the embodiment of the present invention 2 preparations, every day twice, each 50g, 7 days was 1 course for the treatment of, took continuously after two courses for the treatment of, and 21 examples are cured, and effectively, 3 examples are invalid, total effective rate 96.3% for 56 examples.

Claims (2)

1. treat the dyspeptic Chinese medicine composition of hepatopath, it is characterized in that being formed according to weight fraction by following component:
Rhizoma Atractylodis 30-40 part, Cortex Magnoliae Officinalis 30-40 part, Fructus Chaenomelis 30-40 part, Massa Medicata Fermentata 30-40 part, Rhizoma Cyperi 20-30 part, Radix Bupleuri 20-30 part, Flos Rosae Chinensis 20-30 part, Radix Linderae 20-30 part, Rhizoma Zingiberis Recens 10-20 part, Radix Gentianae 10-20 part.
2. the dyspeptic Chinese medicine composition for the treatment of hepatopath according to claim 1, is characterized in that being comprised of according to weight fraction following component:
35 parts of Rhizoma Atractylodis, 35 parts of Cortex Magnoliae Officinalis, 35 parts of Fructus Chaenomeliss, 35 parts of Massa Medicata Fermentata, 25 parts of Rhizoma Cyperis, 25 parts of Radix Bupleuri, 25 parts of Flos Rosae Chinensiss, 25 parts of the Radixs Linderae, 15 parts, Rhizoma Zingiberis Recens, 15 parts of Radix Gentianaes.
CN201310597932.4A 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath Expired - Fee Related CN103638485B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310597932.4A CN103638485B (en) 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310597932.4A CN103638485B (en) 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath

Publications (2)

Publication Number Publication Date
CN103638485A true CN103638485A (en) 2014-03-19
CN103638485B CN103638485B (en) 2015-11-18

Family

ID=50243857

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310597932.4A Expired - Fee Related CN103638485B (en) 2013-11-22 2013-11-22 One treats the dyspeptic Chinese medicine composition of hepatopath

Country Status (1)

Country Link
CN (1) CN103638485B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104154718A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method of cortex magnoliae officinalis
CN104180611A (en) * 2014-08-25 2014-12-03 济南康众医药科技开发有限公司 Application of freeze-drying technology in mangnolia officinalis
CN104197646A (en) * 2014-08-25 2014-12-10 济南康众医药科技开发有限公司 Drying method of magnolia officinalis and application of magnolia officinalis product

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
宋跃龙: "香乌汤治疗功能性消化不良62例", 《湖北中医杂志》, vol. 26, no. 3, 10 March 2004 (2004-03-10), pages 45 *
王晓敏 等: "中医药对功能性消化不良的整体研究", 《甘肃科技》, vol. 24, no. 12, 23 June 2008 (2008-06-23), pages 146 - 149 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104154718A (en) * 2014-08-25 2014-11-19 济南康众医药科技开发有限公司 Drying method of cortex magnoliae officinalis
CN104180611A (en) * 2014-08-25 2014-12-03 济南康众医药科技开发有限公司 Application of freeze-drying technology in mangnolia officinalis
CN104197646A (en) * 2014-08-25 2014-12-10 济南康众医药科技开发有限公司 Drying method of magnolia officinalis and application of magnolia officinalis product

Also Published As

Publication number Publication date
CN103638485B (en) 2015-11-18

Similar Documents

Publication Publication Date Title
CN103055260B (en) Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof
CN103211932B (en) Traditional Chinese medicine composition for treating rheumatism
CN103638485A (en) Chinese medicinal composition for treating dyspepsia of hepatopathy patients
CN104667035A (en) Medicament for treating gout
CN104001131B (en) A kind of Chinese medicine for oral administration preventing and treating stress ulcer
CN103751290B (en) One treats psoriatic pharmaceutical composition
CN103432501B (en) A kind of preparation method of the Chinese medicine composition and preparation thereof for treating chronic colitis
CN104740569A (en) Chinese medicinal umbilical patch for treating infantile diarrhea
CN104043089A (en) Medical biological dressing suppository for treating hemorrhoid
CN104147524A (en) Traditional Chinese medicine preparation for treating peptic ulcer
CN102961696B (en) Chinese medicinal composition for treating diabetic nephropathy edema
CN105213870A (en) A kind of Chinese medicine composition for the treatment of chronic bronchitis
CN104548037A (en) Traditional Chinese medicine composition for treating chronic eczema
CN105311520A (en) Traditional Chinese medicine liniment for treating traumatic injuries
CN104523965A (en) Nephritis treating traditional Chinese medicine composition
CN104398949A (en) Traditional Chinese medicine oral liquid for treating prostatitis
CN103768290A (en) Traditional Chinese medicine composition for treating synovitis and preparation method thereof
CN105727140A (en) Traditional Chinese medicine composition used for treating chronic renal failure
CN105797044A (en) Traditional Chinese medicinal composition for treating gastric ulcer
CN106581358A (en) Chinese medicine prescription for treating liver and stomach disharmony-type indigestion
CN105288528A (en) Medicinal liquor for treating spleen-stomach disharmony
CN104873862A (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN105213865A (en) A kind of Chinese medicine composition for the treatment of coronary heart disease
CN105497392A (en) Traditional Chinese medicine formula for treating dyspepsia in the type of liver-stomach disharmony
CN104435979B (en) A kind of medicine for treating rheumatic lumbocrural pain pain

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151118

Termination date: 20161122